Neural Therapeutics Inc. (CSE:NURL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0250
0.00 (0.00%)
At close: Apr 1, 2025

Neural Therapeutics Balance Sheet

Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Jan '25 Jul '24 Jul '23 Jul '22
Cash & Equivalents
0.550.070.270.37
Cash & Short-Term Investments
0.550.070.270.37
Cash Growth
678.41%-75.56%-26.50%-
Other Receivables
0.010.030.070.05
Receivables
0.010.030.070.05
Prepaid Expenses
--0.010.03
Other Current Assets
00--
Total Current Assets
0.560.10.350.45
Total Assets
0.560.10.350.45
Accounts Payable
0.070.060.170.18
Accrued Expenses
0.210.230.30.15
Short-Term Debt
0.010.01--
Other Current Liabilities
---0.14
Total Current Liabilities
0.290.310.470.46
Long-Term Debt
-0.370.14-
Other Long-Term Liabilities
0.710.1--
Total Liabilities
10.780.610.46
Common Stock
2.962.912.312.07
Retained Earnings
-4.35-4.14-3.47-2.39
Comprehensive Income & Other
0.960.540.890.32
Shareholders' Equity
-0.44-0.68-0.26-0.01
Total Liabilities & Equity
0.560.10.350.45
Total Debt
0.010.380.14-
Net Cash (Debt)
0.53-0.320.130.37
Net Cash Growth
---64.04%-
Net Cash Per Share
0.01-0.010.000.01
Filing Date Shares Outstanding
66.5365.7765.7736.77
Total Common Shares Outstanding
66.5365.7745.0736.77
Working Capital
0.27-0.21-0.12-0.01
Book Value Per Share
-0.01-0.01-0.01-0.00
Tangible Book Value
-0.44-0.68-0.26-0.01
Tangible Book Value Per Share
-0.01-0.01-0.01-0.00
Source: S&P Global Market Intelligence. Standard template. Financial Sources.